Biotech ETF XBI continues strong

Biotech ETF XBI (and IBB) recently began showing relative strength versus the broad US market.

It now has one of the strongest 6-month charts of any industry group.


Biotech ETF XBI showing strength among major industry groups


On the other hand, our global algorithm picked out a stinker – the Philippines ETF (EPHE).  After a great start to 2016, it has done very poorly relative to other world markets over the last couple of months.




If global investing is your shtick, you may want to look elsewhere.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.